These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3532605)

  • 21. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
    Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled field trial to assess the immunogenicity and safety of rift valley fever clone 13 vaccine in livestock.
    Njenga MK; Njagi L; Thumbi SM; Kahariri S; Githinji J; Omondi E; Baden A; Murithi M; Paweska J; Ithondeka PM; Ngeiywa KJ; Dungu B; Donadeu M; Munyua PM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003550. PubMed ID: 25756501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Pittman PR; Norris SL; Brown ES; Ranadive MV; Schibly BA; Bettinger GE; Lokugamage N; Korman L; Morrill JC; Peters CJ
    Vaccine; 2016 Jan; 34(4):523-530. PubMed ID: 26706271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
    Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
    Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.
    Pittman PR; Liu CT; Cannon TL; Makuch RS; Mangiafico JA; Gibbs PH; Peters CJ
    Vaccine; 1999 Aug; 18(1-2):181-9. PubMed ID: 10501248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths.
    Makoschey B; van Kilsdonk E; Hubers WR; Vrijenhoek MP; Smit M; Wichgers Schreur PJ; Kortekaas J; Moulin V
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004550. PubMed ID: 27031621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
    Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
    Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal.
    Lo MM; Mbao V; Sierra P; Thiongane Y; Diop M; Donadeu M; Dungu B
    Onderstepoort J Vet Res; 2015 May; 82(1):857. PubMed ID: 26244679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extended horizons of Rift Valley fever: current and projected immunogens.
    Eddy GA; Peters CJ
    Prog Clin Biol Res; 1980; 47():179-91. PubMed ID: 7208510
    [No Abstract]   [Full Text] [Related]  

  • 34. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines.
    Reynolds JA; Harrington DG; Crabbs CL; Peters CJ; Di Luzio NR
    Infect Immun; 1980 Jun; 28(3):937-43. PubMed ID: 6772571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius).
    Davies FG; Koros J; Mbugua H
    J Hyg (Lond); 1985 Apr; 94(2):241-4. PubMed ID: 3989285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S; Slack OA; Lokugamage N; Hill TE; Juelich TL; Zhang L; Smith JK; Perez D; Gong B; Freiberg AN; Ikegami T
    Virulence; 2016 Nov; 7(8):871-881. PubMed ID: 27248570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serologic response of man to inactivated Rift Valley fever vaccine.
    Imam IZ; Darwish MA; Hosny AH; Amer T
    J Egypt Public Health Assoc; 1978; 53(3-4):249-52. PubMed ID: 752704
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies to identify Zinga virus as Rift Valley Fever virus.
    Meegan JM; Digoutte JP; Peters CJ; Shope RE
    Lancet; 1983 Mar; 1(8325):641. PubMed ID: 6131312
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
    Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.